UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6401
VictoryShares WestEnd US Sector ETF
MODL
$1.07B
| $70.8K | ﹤0.01% |
+1,895
| New | +$67.9K |
|
6402
Absolute Select Value ETF
ABEQ
$145M
| $70.6K | ﹤0.01% |
2,356
+1,311
| +125% | +$39.5K |
|
6403
DDC Enterprise Ltd
DDC
$19.3M
| $70.6K | ﹤0.01% |
3,692
+3,686
| +61,433% | +$90.9K |
|
6404
Quantum-Si Incorporated
QSI
$176M
| $70.6K | ﹤0.01% |
67,227
-35,933
| -35% | -$57.6K |
|
|
TWN
6405
Taiwan Fund
TWN
$530M
| $70.6K | ﹤0.01% |
1,606
+1,126
| +235% | +$45.2K |
|
|
INZY
6406
DELISTED
Inozyme Pharma
INZY
| $70.3K | ﹤0.01% |
15,773
-32,187
| -67% | -$156K |
|
6407
Bakkt Inc
BKKT
$331M
| $70.3K | ﹤0.01% |
3,717
-318
| -8% | -$4.29K |
|
|
MRSN
6408
DELISTED
Mersana Therapeutics
MRSN
| $70.3K | ﹤0.01% |
1,399
-10,188
| -88% | -$737K |
|
6409
Aquestive Therapeutics
AQST
$489M
| $70.3K | ﹤0.01% |
27,038
+25,038
| +1,252% | +$83.6K |
|
|
LENZ
6410
LENZ Therapeutics
LENZ
$170M
| $70.2K | ﹤0.01% |
4,062
-209
| -5% | -$3.65K |
|
6411
Consumer Portfolio Services
CPSS
$205M
| $70.2K | ﹤0.01% |
7,163
-1,333
| -16% | -$11.4K |
|
6412
Pro-Dex
PDEX
$213M
| $70K | ﹤0.01% |
3,564
| – | – |
|
6413
Loar Holdings
LOAR
$6.71B
| $69.9K | ﹤0.01% |
+1,309
| New | +$70.9K |
|
6414
LeaderShares AlphaFactor Tactical Focused ETF
LSAT
$64.8M
| $69.8K | ﹤0.01% |
1,823
-2,205
| -55% | -$83K |
|
6415
FT Vest US Equity Deep Buffer ETF February
DFEB
$466M
| $69.5K | ﹤0.01% |
1,723
+451
| +35% | +$17.7K |
|
6416
AllianzIM U.S. Equity Buffer20 Jul ETF
JULW
$252M
| $69.5K | ﹤0.01% |
2,086
+128
| +7% | +$4.21K |
|
6417
Taboola.com
TBLA
$1.1B
| $69.5K | ﹤0.01% |
20,199
-11,037
| -35% | -$44.5K |
|
6418
National Bankshares
NKSH
$269M
| $69.4K | ﹤0.01% |
2,455
-4,001
| -62% | -$118K |
|
|
OPTZ
6419
Optimize Strategy Index ETF
OPTZ
$269M
| $69.3K | ﹤0.01% |
+2,584
| New | +$68.1K |
|
6420
ICZOOM Group
IZM
$3.05M
| $69.3K | ﹤0.01% |
36,480
+36,169
| +11,630% | +$278K |
|
6421
AllianzIM U.S. Equity Buffer20 May ETF
MAYW
$450M
| $69K | ﹤0.01% |
2,367
-1,531
| -39% | -$43.6K |
|
|
IMA
6422
ImageneBio Inc
IMA
$65.3M
| $69K | ﹤0.01% |
3,485
+756
| +28% | +$13.3K |
|
6423
Direxion Daily Real Estate Bear 3X ETF
DRV
$25.6M
| $69K | ﹤0.01% |
1,862
+1,796
| +2,721% | +$72.5K |
|
6424
Perion Network
PERI
$389M
| $68.9K | ﹤0.01% |
8,247
-21,960
| -73% | -$266K |
|
6425
Franklin FTSE Germany ETF
FLGR
$39.3M
| $68.7K | ﹤0.01% |
2,864
+1,963
| +218% | +$48.3K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.